For Immediate Release: Saturday, October 22, 2022 Contact: Media Relations (404) 639-3286
Last night, CDC Director Dr. Rochelle Walensky tested positive for COVID-19. She is up to date with her vaccines. Dr. Walensky is experiencing mild symptoms. Consistent with CDC guidelines, she is isolating at home and will participate in her planned meetings virtually. CDC senior staff and close contacts have been informed of her positive test and are taking appropriate action to monitor their health.
The Novavax booster, NVX-CoV2373, was previously authorized in other geographies, including in the European Union. In the US, it will be the third COVID-19 booster dose, along with Pfizer-BioNTech and Moderna, available after a primary vaccine series.
At the IDWeek conference, we sat down with Novavax executive director, Clinical Development, Germán Áñez, MD, to learn more about this new non-mRNA booster vaccine.
At 1 month after receiving the Novavax booster vaccination, Añéz said, trial participants had both neutralizing antibody titers and binding IgG titers that were approximately 3 times higher than after primary vaccination. This fulfilled the noninferiority criteria.
Añéz said these results were largely expected, but a surprising result was how well the booster performed against Omicron subvariants. “We tested samples against 3 different flavors of the Omicron variant, BA.1, BA.2, and BA.5,” he said, emphasizing they found high titers even though the booster vaccine does not contain an Omicron sequence.
我认识的人中，只有邻居老夫妻（95岁，92岁）打了，其他人没有打的。他们打了说基本没有什么不适。
已打了第一针,无不良反应.
https://www.cdc.gov/media/releases/2022/s1022-covid-director.html
CDC Director Tests Positive For COVID-19For Immediate Release: Saturday, October 22, 2022
Contact: Media Relations
(404) 639-3286
Last night, CDC Director Dr. Rochelle Walensky tested positive for COVID-19. She is up to date with her vaccines. Dr. Walensky is experiencing mild symptoms. Consistent with CDC guidelines, she is isolating at home and will participate in her planned meetings virtually. CDC senior staff and close contacts have been informed of her positive test and are taking appropriate action to monitor their health.
是吧？
https://www.contagionlive.com/view/adjuvanted-novavax-booster-adapts-to-new-variants
The Novavax booster, NVX-CoV2373, was previously authorized in other geographies, including in the European Union. In the US, it will be the third COVID-19 booster dose, along with Pfizer-BioNTech and Moderna, available after a primary vaccine series.
At the IDWeek conference, we sat down with Novavax executive director, Clinical Development, Germán Áñez, MD, to learn more about this new non-mRNA booster vaccine.
At 1 month after receiving the Novavax booster vaccination, Añéz said, trial participants had both neutralizing antibody titers and binding IgG titers that were approximately 3 times higher than after primary vaccination. This fulfilled the noninferiority criteria.
Añéz said these results were largely expected, but a surprising result was how well the booster performed against Omicron subvariants. “We tested samples against 3 different flavors of the Omicron variant, BA.1, BA.2, and BA.5,” he said, emphasizing they found high titers even though the booster vaccine does not contain an Omicron sequence.
为啥打，为了下月去日本，我打了三针未满18的孩子就豁免了，72小时PCR都不需要。